Acknowledgement
- PDF / 35,554 Bytes
- 1 Pages / 610 x 823 pts Page_size
- 2 Downloads / 156 Views
Int J Pharm Med 2003; 17 (5-6): 179 1364-9027/03/0005-0179/$30.00/0 © 2003 Adis Data Information BV. All rights reserved.
Dear Readers
We hope you have enjoyed the articles published in the International Journal of Pharmaceutical Medicine this year. Subjects have covered a diverse range including Icelandic genetics, functional foods, imaging techniques in drug development, experiences of CROs in the UK and Germany, pharmacovigilance, and drug advertising, in addition to our regular features of news items and the IFAPP and Society of Pharmaceutical Medicine news sections. We have also carried some lighter-hearted articles on historical aspects of the drug industry. We would like to take this opportunity to highlight below some of the achievements of 2003, and changes in 2004, for our other journals:
• Drugs ranked number 4 in the ScienceWatch list of top pharmacology and toxicology journals of the decade (1992–2002). For this ranking, ScienceWatch used ISI data to determine the number of references to Drugs articles made in other publications over this time period.
• The ISI impact factor for BioDrugs more than doubled over the previous year, and also improved significantly for CNS Drugs. Both journals also markedly improved rankings in their respective journal categories. Other journals have continued to maintain their high standing over time.
• We officially launched a new peer-reviewed journal, the American Journal of Drug Delivery, at the annual meeting of the International Controlled Release Society.
• Disease Management & Health Outcomes will be refocused for 2004 to provide more content of specific interest to the pharmaceutical industry, an important stakeholder group in disease management. The American Journal of Clinical Dermatology will be including more evidence-based reviews of drugs and devices in the treatment of dermatological conditions, and Pediatric Drugs will concentrate on recent advances and controversial issues regarding drug therapy for children. Furthermore, the American Journal of Respiratory Medicine has been renamed Treatments in Respiratory Medicine, to reflect the international content of this journal.
• Finally, we are proud to have gained indexing on Medline/Index Medicus for the American Journal of Cardiovascular Drugs and Treatments in Respiratory Medicine, and on Embase/Excerpta Medica for the American Journal of Cancer, Treatments in Endocrinology and Treatments in Respiratory Medicine. We would like to take this opportunity to thank all of the authors who have written articles published in the International Journal of Pharmaceutical Medicine over the past 12 months. The quality of articles not only reflects the efforts of the authors, but also the input of peer reviewers. The assistance of peer reviewers has been invaluable in ensuring that we continue to publish articles that are of the highest standard. Much of the peer reviewing of submitted articles is carried out by members of the Editorial Board, but in addition we would like to thank the following people who have ac
Data Loading...
